EGFR and head and neck squamous cell carcinoma: Additionally noteworthy, Bothwell et al. [200] analysed the effect of calcitriol on the chemopreventive efficacy of the EGFR inhibitor erlotinib against HNSCC in patient-derived xenografts (PDX) and the 4NQO carcinogen-induced HNSCC model.